Oxford Global Conferences is proud to present 2nd Annual Proteins Congress, which is to be held on the 29th -30th October 2009 in Berlin. The congress is the single most focused event in Europe dedicated to key technological and scientific trends in proteins engineering, expression and discovery in the Biopharma, pharmaceutical and biotech industry.

With the ever-expanding protein therapeutic market, there is a need for the bio/pharma industry to reassess the technology, discovery and delivery trends. Protein expression & characterisation systems are rapidly evolving, and there is more pressure to harvest larger, purer quantities of product to support research pipelines. More efficient methods are also needed to identify and analyse proteins involved in disease populations with the aim to discover novel diagnostic tools and treatments. The conference also looks at effective strategies in protein assays and microarrays and data mining in discovery.

Over two days, the 2 events will attract over 120 senior-level decision makers working in Proteins development from the UK, Europe and US. This prestigious event provides a forum for practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment, during a 2 day conference programme.

THE EVENT
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 45 speakers will present a full conference programme covering the following key topics include:


PLENARY SESSIONS
Strategies in Therapeutic Proteins and Antibodies for Different Therapeutic Market
Novel Approaches and Technologies for Protein Therapeutics in Drug Discovery

STREAM 1:
PROTEIN EXPRESSION & PURIFICATION
Examining strategies in designing a protein expression systems, localisation and parallel approaches
PROTEIN PRODUCTION
Meeting protein production demands in the biopharmaceutical development and production processes and scale up
PROTEIN CHARACTERISATION
Innovations in the expression and characterisation of proteins and therapeutics
MAMMALIAN CELLS
Expression and production scale up

STREAM 2:
SCREENING TECHNIQUES & NOVEL TECHNOLOGIES
Evaluating different cost effective screening methods and novel technologies to accelerate production, automation, delivery and discovery
DRUG DISCOVERY – VALIDATION
Using mass spectrometry in driving biological discovery, protein micro-array and assay development, as well as datamining

STREAM 3:
BIOTHERAPEUTICS LANDSCAPE
Exploiting key growth areas for the protein therapeutics market, the technologies, trends
DELIVERY: ENGINEERING PROTEIN BIOTHERAPEUTICS
Leveraging on Tools and Technologies for Protein Delivery






WHO ATTENDS?

Delegates are pre-qualified dependent on budget, responsibility and seniority. Delegates are senior-level decision makers, from major pharmaceutical, biopharmaceutical, biotech companies and research institutions based in Europe and typically include VPs, Directors, Managers and Heads of:

Protein Engineering Structural Chemistry Molecular Research Proteomics
Structural Biology Protein Science Biopharmaceutical Development Bioformulations
Discovery Biochemistry Bioinformatics Biomarkers
Bioresearch Biotherapeutics Technology Development Medical Sciences

Registration starts from £400